NIV's Mumbai team uses CRISPR to develop poliovirus-free cell line https://ift.tt/HEuLn1A

Researchers from the Mumbai unit of the National Institute of Virology (NIV) have used the cutting-edge gene-editing tool, CRISPR/Cas9, to develop a poliovirus-free cell line for use in research work in laboratories. Many clinical trials and research using CRISPR/Cas9 are underway across the world, but there have only been a few from India.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/k9uEHaO